Freyr offers end-to-end pharmaceutical regulatory services in China, including NMPA registration, regulatory strategy, IND support, eCTD publishing, dossier preparation, lifecycle management, and local regulatory representation.
Freyr offers end-to-end pharmaceutical regulatory services in China, including NMPA registration, regulatory strategy, IND support, eCTD publishing, dossier preparation, lifecycle management, and local regulatory representation.